CD8A and neoplasm: Ultimately, pancreatic cancer cells, in concert with its TME, tailor the tumor niche in such a way that it promotes tumor growth while acting as a barrier against a systemic immune response and suppresses anti-tumor immune invasion by cytotoxic CD8+ T lymphocytes [79].